The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Independent Analysis of Permian Well results

17 Feb 2010 07:41

RNS Number : 2644H
ViaLogy PLC
17 February 2010
 



VIALOGY PLC

 

INDEPENDENT ANALYSIS VERIFIES VIALOGY

PERMIAN WELL PREDICTIONS

 

London, February 17. ViaLogy (LSE:VIY) announces the start of oil production from a recently completed successful well in the Strawn formation in Texas, and independent confirmation of ViaLogy's reservoir attribute predictions. The client specified that ViaLogy find Strawn with significant thickness to make a commercially successful well; that major zones of porosity over 4% be identified; and that the selected Strawn section exhibit natural fracturing to enable optimal production.

Final well and formation micro-imaging (FMI) logs, done by Halliburton, show that QuantumRD directly detected and predicted a 220 foot continuous Strawn section. Within this section, ViaLogy's pre-drilling analysis located high porosity limestone zones - totaling over 80 feet with more than 4% porosity. Logging showed a continuous zone of 50 feet with greater than 6% porosity, and reaching 10 to 12%. The ability of the technology to find and distinguish between such small variations in limestone porosity demonstrates QuantumRD's sensitivity, and its utility in mapping the Strawn and other formations where porosity is a critical factor in determining a well's economic viability. In addition, the analysis also verified that QuantumRD located natural fractures enhancing the reservoir's permeability and enabling extraction to be optimized. ViaLogy's contract prohibits identifying the client.

This ViaLogy-positioned well is in the Permian Basin, one of the largest structural basins and most prolific petroleum provinces in North America, extending approximately 86,000 sq miles over Texas and New Mexico. It sits in the naturally fractured Spraberry Trend Area in west Texas covering approximately 2,500 square miles over a six county area. Estimated to hold 6-10 billion bbls of oil, this trend area has huge potential for future recovery as only about 700 million bbls have been produced over the past 50 years. This is due in part to the analytical challenges of finding high porosities and developing economically viable wells in the carbonate, limestone and/or dolomite platform, and to natural fractures in a rock matrix with inherently low permeability. Also, unlike conventional faulted sandstone reservoirs, the Permian platform is a stratigraphic formation with discontinuities over small areas. Current exploration technologies and basin geology models provide limited insight for positioning individual wells and offsets, as the formation properties change unpredictably due to complex cementation and matrix dissolution processes. QuantumRD's more innovative computational approach to characterize the subsurface and locate drilling targets should assist in the Permian Basin's exploitation.

Robert Dean, ViaLogy CEO, said, "Independent confirmation of QuantumRD's Strawn success further validates the technology's power. ViaLogy's work is done on the basis of specific client drilling requirements - they tell us what quantifiable characteristics to find, such as porosity, and this can vary depending upon the location, formation characteristics and land area where a client wants to drill. We offer an 'energy solution' - the ability to identify drilling sites, depths, porosities and trends based on a synergistic integration of rock physics, 3-D and multi-component seismic data, and depositional geology. In this well we used QuantumRD, our proprietary weak signal detection technology, to locate regions of high porosity within a range of carbonate sizes that are key for positioning successful Permian wells."

He added, "Our technology can be applied to virtually any hydrocarbon formation, and we have a growing customer list and backlog that will take us into other areas of the Permian and other completely different areas. We are now finalizing our next drilling recommendation location on this particular Strawn prospect, and we intend to deliver another success to our client. We are also in discussions with several exploration & production firms to deliver QuantumRD analysis on the Permian."

 

ViaLogy PLC

 

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756)

 

 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy +44 (0) 20-7107-8000

 

 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com.

 

 

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results,

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLDDLBFBLFXBBK
Date   Source Headline
5th Nov 20207:00 amRNSDirectorate Change
3rd Nov 20207:00 amRNSPartnership with Take2 Health Limited
26th Oct 20207:00 amRNSHalf-year Trading update
23rd Oct 20207:00 amRNSCQC accreditation
21st Oct 20207:00 amRNSYourgene Genomic Services collaboration with Cytox
12th Oct 20207:00 amRNSElucigene DPYD tests to be used routinely in Wales
8th Oct 20207:00 amRNSStrategic reproductive health partnership in Japan
7th Oct 20207:00 amRNSIONA®Nx awarded contract with St George’s Hospital
5th Oct 20207:00 amRNSShare Incentive Plan
1st Oct 20204:59 pmRNSCorrection: Holding(s) in Company
1st Oct 20203:29 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSLaunch of Yourgene Genomic Services
25th Sep 20205:28 pmRNSIssue of Share Options
24th Sep 202010:00 amRNSDPD reimbursement in Germany
24th Sep 20207:00 amRNSDirector/PDMR Shareholding
23rd Sep 20205:20 pmRNSExercise of Options
23rd Sep 202012:25 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:14 pmRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Statement
21st Sep 20207:00 amRNSUS distribution agreement for DPYD &other products
9th Sep 20207:00 amRNSAGM update and investor presentation
3rd Sep 20207:00 amRNSIONA® Nx Launch
28th Aug 20207:00 amRNSNotice of AGM & Annual Report 2020
13th Aug 20207:00 amRNSTGA approves IONA® Nx for sale in Australia
11th Aug 20207:00 amRNSAdmission of Company Considerations Shares and TVR
7th Aug 20203:42 pmRNSHolding(s) in Company
7th Aug 20203:25 pmRNSHolding(s) in Company
7th Aug 20209:48 amRNSHolding(s) in Company
5th Aug 20201:15 pmRNSResult of Placing
5th Aug 20207:00 amRNS£16.15m Placing & Close of Accelerated Bookbuild
4th Aug 20205:13 pmRNSProposed Acquisition and Placing
3rd Aug 20207:00 amRNSCE-IVD Mark for Clarigene™ SARS-CoV-2 test
29th Jul 202012:05 pmRNSAppointment of Joint Broker
28th Jul 20207:00 amRNSFinal Results
13th Jul 20201:13 pmRNSNotice of Results
30th Jun 20207:00 amRNSCOVID-19 assay launched
19th Jun 20204:44 pmRNSIssue of Share Options
16th Jun 20207:00 amRNSCollaboration in COVID-19 testing
15th Jun 20207:00 amRNSCE-IVD mark received for Illumina-based IONA® test
26th May 202012:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSCOVID-19 testing service launch; business update
20th May 20207:00 amRNSExercise of Warrants and Options
20th Apr 20207:00 amRNSYear-end Trading update: Revenues increase 86%
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSPresentation on ‘Adapting during crisis’

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.